Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients

por Yamasaki, Satoshi, Kada, Akiko, Choi, Ilseung, Iida, Hiroatsu, Sekiguchi, Naohiro, Harada, Naoko, Sawamura, Morio, Shimomura, Takeshi, Komeno, Takuya, Yano, Takahiro, Yoshida, Isao, Yoshida, Shinichiro, Sunami, Kazutaka, Hishita, Terutoshi, Takatsuki, Hiroshi, Ohshima, Koichi, Takeshita, Morishige, Saito, Akiko M., Iwasaki, Hiromi, Nagai, Hirokazu
Publicado 2020